SUBLEASE AMENDMENT NO. 1Editas Medicine, Inc. • September 2nd, 2016 • Biological products, (no disgnostic substances) • Massachusetts
Company FiledSeptember 2nd, 2016 Industry JurisdictionThis Sublease Amendment No. 1 (this “Amendment”) is made as of this 31st day of August, 2016 by and between ALNYLAM PHARMACEUTICALS, INC., a Delaware corporation (“Sublessor”) and EDITAS MEDICINE, INC., a Delaware corporation (“Sublessee”).